Comparison of the effects of low-dose vs. high-dose aminophylline on lung function in experimental meconium

D Mokra1, A Drgova, J Mokry

  • 1Department of Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. mokra@jfmed.uniba.sk

Insights

High-dose aminophylline significantly improved lung function in meconium aspiration syndrome (MAS) models, outperforming low-dose treatments. This suggests higher doses are more effective for treating MAS-related respiratory distress.

Area of Science:

  • Neonatal Medicine
  • Pulmonary Pharmacology
  • Respiratory Physiology

Background:

  • Meconium aspiration syndrome (MAS) poses significant risks to newborns, often requiring respiratory support.
  • Optimal therapeutic strategies, particularly aminophylline dosing, remain under-investigated in MAS.
  • Existing research lacks clear guidelines on aminophylline's efficacy in MAS treatment.

Purpose of the Study:

  • To compare the effects of high-dose (HD) versus low-dose (LD) aminophylline on lung function in a rabbit model of MAS.
  • To evaluate aminophylline's impact on gas exchange, pulmonary hemodynamics, inflammation, and oxidative stress in MAS.
  • To determine the optimal dosage of aminophylline for managing MAS complications.

Main Methods:

  • MAS was induced in rabbits via meconium instillation.
  • Animals received either HD (2.0 mg/kg) or LD (1.0 mg/kg) aminophylline at 0.5 and 2.5 hours post-instillation, or served as untreated controls.
  • Lung function parameters, including gas exchange, ventilatory pressures, edema, neutrophils, peroxidation, and tracheal reactivity, were assessed within 5 hours of ventilation.

Main Results:

  • HD-aminophylline significantly improved gas exchange, reduced pulmonary shunts, ventilatory pressures, edema, and lung neutrophils compared to controls.
  • LD-aminophylline showed some lung function improvement but was less effective than HD-aminophylline, failing to reduce edema or neutrophils.
  • Both doses reduced lung peroxidation, with HD-aminophylline showing a stronger effect on lipid oxidation and LD-aminophylline on protein oxidation. Tracheal reactivity decreased with both treatments, more so in lung tissue with LD-aminophylline.

Conclusions:

  • High-dose aminophylline demonstrates superior efficacy in improving lung function and mitigating key pathological features of MAS compared to low-dose administration.
  • While LD-aminophylline exhibits some anti-inflammatory effects, HD-aminophylline provides more comprehensive benefits in managing MAS.
  • Further clinical investigation into HD-aminophylline for MAS treatment is warranted based on these findings.